Publications by authors named "Allison Perrin"

Claim this Profile
V
Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial.
D P Devanand, Thomas Wisniewski, Qolamreza Razlighi, Min Qian, Renjie Wei, Allison C Perrin

JAMA· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Developing Topics.
Davangere P Devanand, Thomas Wisniewski, Qolamreza R Razlighi, Min Qian, Renjie Wei, Allison L Perrin

Alzheimers Dement· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.
Adam S Fleisher, Michael J Pontecorvo, Michael D Devous, Ming Lu, Anupa K Arora, Allison Perrin

JAMA Neurol· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cost-per-responder analysis comparing romiplostim to rituximab in the treatment of adult primary immune thrombocytopenia in Spain].
M Fernanda López, María Eva Mingot, David Valcárcel, Vicente Vicente García, Allison Perrin

Med Clin (Barc)· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lifetime cost of everolimus vs axitinib in patients with advanced renal cell carcinoma who failed prior sunitinib therapy in the US.
Allison Perrin, Steven Sherman, Sumanta Pal, Andrew Chua, Magdaliz Gorritz

J Med Econ· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States.
Roman Casciano, Maruit Chulikavit, Allison Perrin, Zhimei Liu, Xufang Wang

J Med Econ· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis